With respect to tumor maintenance and progression resulting from constitutive NFκB activation [39,40], the specific cellular activation status of PP2A should be considered by support of mathematical models, and may consequently help to elucidate alternative therapeutic targets to fight individual cancers. The gene discussed is PTPA; the disease is cancer.